Oral humatin (paromomycin) in chronic enteric carriers

Abstract

A clinical trial to determine the effect of oral Humatin therapy on the course of the chronic enteric carrier state in a group of twenty-seven typhoid and paratyphoid B carriers is described. It is concluded that the drug when administered orally in this group of carriers fails in the dosage given to effect a cure of the carrier state.